Europeans now eyeing Chinese jabs

Shortage of approved vaccines prompts demands for more alternative solutions

BELGRADE, Serbia－As Hungary joined Serbia in spearheading mass inoculation with China's Sinopharm COVID-19 vaccine in Europe, other European countries are struggling against a vaccine delivery crisis as they search for a way out of lockdowns and into economic recovery.

In around a month, 14 percent of Serbia's 6.5-million population received their first doses of vaccine against COVID-19, thanks to the 1.5 million China-made doses.

Following its neighbor, Hungary on Jan 31 announced it has reached a deal with Sinopharm, which will enable a mass immunization of its 2.5 million people.